112 related articles for article (PubMed ID: 26740209)
1. Identification of New Inhibitors for Human SIRT1: An in-silico Approach.
Padmanabhan B; Ramu M; Mathur S; Unni S; Thiyagarajan S
Med Chem; 2016; 12(4):347-61. PubMed ID: 26740209
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of the inhibitory effects of polyphenols, (+)-hopeaphenol and (-)-isohopeaphenol, on human SIRT1.
Loisruangsin A; Hikita K; Seto N; Niwa M; Takaya Y; Kaneda N
Biofactors; 2019 Mar; 45(2):253-258. PubMed ID: 30537158
[TBL] [Abstract][Full Text] [Related]
3. Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products.
Sun Y; Zhou H; Zhu H; Leung SW
Sci Rep; 2016 Jan; 6():19312. PubMed ID: 26805727
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay.
Uba AI; Yelekçi K
J Biomol Struct Dyn; 2018 Sep; 36(12):3231-3245. PubMed ID: 28938863
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic structure of a small molecule SIRT1 activator-enzyme complex.
Dai H; Case AW; Riera TV; Considine T; Lee JE; Hamuro Y; Zhao H; Jiang Y; Sweitzer SM; Pietrak B; Schwartz B; Blum CA; Disch JS; Caldwell R; Szczepankiewicz B; Oalmann C; Yee Ng P; White BH; Casaubon R; Narayan R; Koppetsch K; Bourbonais F; Wu B; Wang J; Qian D; Jiang F; Mao C; Wang M; Hu E; Wu JC; Perni RB; Vlasuk GP; Ellis JL
Nat Commun; 2015 Jul; 6():7645. PubMed ID: 26134520
[TBL] [Abstract][Full Text] [Related]
6. Novel acridinedione derivatives: design, synthesis, SIRT1 enzyme and tumor cell growth inhibition studies.
Alvala M; Bhatnagar S; Ravi A; Jeankumar VU; Manjashetty TH; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2012 May; 22(9):3256-60. PubMed ID: 22464458
[TBL] [Abstract][Full Text] [Related]
7. In Silico Design of Novel Sirtuin 1 Enzyme Activators for the Treatment of Age-related Diseases and Life Span.
Ertan-Bolelli T; Bolelli K
Curr Comput Aided Drug Des; 2021; 17(3):412-420. PubMed ID: 32321406
[TBL] [Abstract][Full Text] [Related]
8. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1).
Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P
J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
[TBL] [Abstract][Full Text] [Related]
10. Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors.
Therrien E; Larouche G; Nguyen N; Rahil J; Lemieux AM; Li Z; Fournel M; Yan TP; Landry AJ; Lefebvre S; Wang JJ; MacBeth K; Heise C; Nguyen A; Besterman JM; Déziel R; Wahhab A
Bioorg Med Chem Lett; 2015 Jun; 25(12):2514-8. PubMed ID: 25971769
[TBL] [Abstract][Full Text] [Related]
11. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies.
Uba AI; Yelekçi K
Comput Biol Chem; 2018 Aug; 75():131-142. PubMed ID: 29859380
[TBL] [Abstract][Full Text] [Related]
12. In silico and in vitro identification of candidate SIRT1 activators from Indonesian medicinal plants compounds database.
Azminah A; Erlina L; Radji M; Mun'im A; Syahdi RR; Yanuar A
Comput Biol Chem; 2019 Dec; 83():107096. PubMed ID: 31377446
[TBL] [Abstract][Full Text] [Related]
13. Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and In Vitro Testing.
Karaman B; Alhalabi Z; Swyter S; Mihigo SO; Andrae-Marobela K; Jung M; Sippl W; Ntie-Kang F
Molecules; 2018 Feb; 23(2):. PubMed ID: 29443909
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
15. In Silico Approach to Finding New Active Compounds from Histone Deacetylase (HDAC) Family.
Yanuar A; Azminah EY; Andika EY; Erlina L; Syahdi RR
Curr Pharm Des; 2016; 22(23):3488-97. PubMed ID: 27075581
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6.
Uba AI; Yelekçi K
Comput Biol Chem; 2018 Dec; 77():318-330. PubMed ID: 30463049
[TBL] [Abstract][Full Text] [Related]
17. Rational Drug Discovery of HCV Helicase Inhibitor: Improved Docking Accuracy with Multiple Seeding in AutoDock Vina and In Situ Minimization.
Lim SK; Othman R; Yusof R; Heh CH
Curr Comput Aided Drug Des; 2017; 13(2):160-169. PubMed ID: 27903217
[TBL] [Abstract][Full Text] [Related]
18. Measuring Activity of Native Plant Sirtuins - The Wheat Mitochondrial Model.
Soccio M; Laus MN; Alfarano M; Pastore D
Front Plant Sci; 2018; 9():961. PubMed ID: 30026749
[TBL] [Abstract][Full Text] [Related]
19. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
20.
Sarı S; Avci A; Koçak Aslan E
Turk J Pharm Sci; 2021 Dec; 18(6):730-737. PubMed ID: 34978402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
